Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

NCT00893789 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

117

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been stopped by sponsor decision.

Conditions

Traumatic Brain Injury

Interventions

DRUG: Armodafinil
DRUG: Armodafinil
DRUG: Armodafinil
OTHER: Placebo

Sponsor

Cephalon, Inc.